Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$73M Buy
642,894
+149,586
+30% +$17.8M 0.34% 63
2024
Q2
$61.1M Sell
493,308
-12,803
-3% -$1.65M 0.39% 56
2024
Q1
$66.8M Buy
506,111
+81,240
+19% +$10M 0.56% 38
2023
Q4
$46.3M Buy
424,871
+318,230
+298% +$33M 0.36% 65
2023
Q3
$11M Buy
106,641
+103,641
+3,455% +$11.2M 0.07% 208
2023
Q2
$346K Buy
+3,000
New +$341K ﹤0.01% 339
2022
Q2
Sell
-575,800
Closed -$47.6M 480
2022
Q1
$47.6M Buy
+575,800
New +$45.4M 0.8% 27

Other funds holding MRK

Eisler Capital (UK)'s MRK Position: Q3 2024 in Review

Eisler Capital (UK) opened a new position in Merck (MRK) in Q3 2024: 44,126 shares worth $5.01M. The stake represents 0.02% of the portfolio and ranks #360 among its holdings. This is a return to the name: Eisler Capital (UK) previously reported a position in MRK as recently as Q1 2024.

Eisler Capital (UK) first reported a position in MRK in Q4 2023 and has held it in 3 quarters since. 3,489 funds tracked by Wall St. Rank hold MRK as of Q3 2024.

  • Eisler Capital (UK) held 44,126 shares of Merck worth $5.01M as of Q3 2024.
  • Merck was a new Eisler Capital (UK) position in Q3 2024.
  • Merck made up 0.02% of Eisler Capital (UK)'s portfolio in Q3 2024, its #360 holding.
  • Eisler Capital (UK) first reported a position in Merck in Q4 2023 and has held it in 3 quarters since.
  • 3,489 funds tracked by Wall St. Rank held Merck as of Q3 2024.

Based on Eisler Capital (UK)'s 13F filing for Q3 2024, filed 14 Nov 2024.